Attovia Therapeutics, Inc.
ATTO
IPO
$22.86
-$0.80-3.38%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 115.13M | 132.62M | -- | ||
| Total Receivables | 900.00K | 700.00K | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 2.37M | 3.32M | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | 118.40M | 136.64M | -- | ||
|
|
|||||
| Total Current Assets | 118.40M | 136.64M | -- | ||
| Net Property, Plant & Equipment | 6.92M | 7.49M | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 3.03M | 1.95M | -- | ||
| Total Assets | 128.35M | 146.09M | -- | ||
|
|
|||||
| Total Accounts Payable | 6.00M | 2.53M | -- | ||
| Total Accrued Expenses | 4.58M | 4.84M | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 2.04M | 1.98M | -- | ||
| Total Finance Division Other Current Liabilities | -- | 450.00K | -- | ||
| Total Other Current Liabilities | -- | 450.00K | -- | ||
| Total Current Liabilities | 12.62M | 9.80M | -- | ||
|
|
|||||
| Total Current Liabilities | 12.62M | 9.80M | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | 2.29M | 2.83M | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | 678.00K | 750.00K | -- | ||
| Total Liabilities | 15.58M | 13.38M | -- | ||
|
|
|||||
| Common Stock & APIC | 4.97M | 4.18M | -- | ||
| Retained Earnings | -150.35M | -129.67M | -- | ||
| Treasury Stock & Other | -79.00K | -27.00K | -- | ||
| Total Common Equity | -145.46M | -125.52M | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | 258.23M | 258.23M | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | 258.23M | 258.23M | -- | ||
|
|
|||||
| Total Common Equity | -145.46M | -125.52M | -- | ||
| Total Preferred Equity | 258.23M | 258.23M | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 112.77M | 132.71M | -- | ||
|
|
|||||